UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TSE-CNN: A Two-Stage End-to-End CNN for Human Activity Recognition

IEEE journal of biomedical and health informatics, 2020-01, Vol.24 (1), p.292-299

2020

Volltextzugriff (PDF)

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Nature communications, 2022-02, Vol.13 (1), p.857-12, Article 857

2022

Volltextzugriff (PDF)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy

Nutrients, 2023-10, Vol.15 (19), p.4290

2023

Volltextzugriff (PDF)

Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma

Scientific reports, 2017-04, Vol.7 (1), p.753-753, Article 753

2017

Volltextzugriff (PDF)

PD-1 inhibitors-based second-line therapy for metastatic gastric cancer

Frontiers in immunology, 2023-05, Vol.14, p.1136437-1136437

2023

Volltextzugriff (PDF)

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2376429

2024

Volltextzugriff (PDF)

Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2414546

2024

Volltextzugriff (PDF)

Efficacy and safety of nivolumab for metastatic biliary tract cancer

OncoTargets and therapy, 2019-01, Vol.12, p.861-867

2019

Volltextzugriff (PDF)

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

BMC cancer, 2024-01, Vol.24 (1), p.67-67, Article 67

2024

Volltextzugriff (PDF)

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-01, Vol.18 (1), p.168-176

2015

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

Journal of Immunology Research, 2021-12, Vol.2021, p.2549295-9

2021

Volltextzugriff (PDF)

Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity

Chinese medical journal, 2022-03, Vol.135 (5), p.606-618

2022

Volltextzugriff (PDF)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy

Frontiers in immunology, 2022-09, Vol.13, p.950868-950868

2022

Volltextzugriff (PDF)

Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis

BMC cancer, 2023-12, Vol.23 (1), p.1196-1196, Article 1196

2023

Volltextzugriff (PDF)

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey

Nutrients, 2023-09, Vol.15 (17), p.3825

2023

Volltextzugriff (PDF)

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

Signal transduction and targeted therapy, 2020-07, Vol.5 (1), p.134-134, Article 134

2020

Volltextzugriff (PDF)

Immune function of colon cancer associated miRNA and target genes

Frontiers in immunology, 2023-07, Vol.14, p.1203070-1203070

2023

Volltextzugriff (PDF)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

Frontiers in oncology, 2022-07, Vol.12, p.851756-851756

2022

Volltextzugriff (PDF)

High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study

Journal of translational medicine, 2024-02, Vol.22 (1), p.184-23, Article 184

2024

Volltextzugriff (PDF)

Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2252692-2252692

2023

Volltextzugriff (PDF)

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Cancer communications (London, England), 2021-11, Vol.41 (11), p.1173-1182

2021

Volltextzugriff (PDF)

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection

Frontiers in surgery, 2023-01, Vol.9, p.1002075-1002075

2023

Volltextzugriff (PDF)

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.234-244

2016

Volltextzugriff (PDF)

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients

BMC cancer, 2017-04, Vol.17 (1), p.242-242, Article 242

2017

Volltextzugriff (PDF)

LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4

Biomedicine & pharmacotherapy, 2020-05, Vol.125, p.109916-109916, Article 109916

2020

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(174)
Chinesisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

TSE-CNN: A Two-Stage End-to-End CNN for Human Activity Recognition

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy

Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma

PD-1 inhibitors-based second-line therapy for metastatic gastric cancer

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy

Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis

Efficacy and safety of nivolumab for metastatic biliary tract cancer

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy

Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis

Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

Immune function of colon cancer associated miRNA and target genes

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China

High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study

Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients

LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4

Suchergebnisse filtern